HealthMyne, which has developed a clinical imaging analytics technology, has raised $4.5 million in a Series A funding round. The platform gives doctors advanced tumor image manipulation, helping them find nodules during low-dose CT lung scans, then allows them to search image repositories and EHRs to find similar cases. The Wisconsin startup will use the money to advance research and development for the platform.
The University of California, Los Angeles, reportedly paid nearly $4.5 million to defend itself and a chemistry professor against charges relating to the death of a staff researcher in a lab fire in 2008. The university has since spent nearly $20 million to address lab safety and funded a $500,000 scholarship in the deceased researcher's name, which helped it avoid charges. The professor reached a deal under which he did not have to plead guilty or no contest to his charges.
The University of Michigan has received a $4.5 million grant from the Department of Education's National Institute of Disability and Rehabilitation Research to help launch the school's Rehabilitation Engineering and Research Center. Researchers will consider how technology can help young adults with disabilities. "There are some things you physically can't fix but there are so many things you can do to improve quality of life -- our job is to keep seeking innovative tools that will help these youth lead productive lives," said Michelle Meade, director of the new research center.
The NIH awarded Thermalin Diabetes a $4.5 million grant to fund development and animal trials of next-generation insulin analogs. Unlike the natural hormone, Thermalin's analogs can be modified to tolerate heat or act faster or slower than insulin to match a patient's needs.
Stemgent made a $4.5 million investment to partner with a Scottish professor to establish Ubiquigent, a cell signaling startup that will be based in Dundee, Scotland. Stemgent plans to market the biological products and services produced by the startup firm in the U.S.